Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended October 31, 2025 (Fiscal Year 2026)
Business Overview: The Company designs, manufactures, and installs scientific and technical furniture and laboratory equipment. A significant development in the period was the full integration of the Nu Aire, Inc. acquisition (closed November 1, 2024), which expanded the Company's product portfolio to include biological safety cabinets, CO2 incubators, and ultralow freezers.
Key Financial Metrics
| Metric ($ in thousands) | 3 Months Ended Oct 31, 2025 | 3 Months Ended Oct 31, 2024 | 6 Months Ended Oct 31, 2025 | 6 Months Ended Oct 31, 2024 |
|---|---|---|---|---|
| Net Sales | $70,096 | $47,764 | $141,200 | $96,157 |
| Gross Profit | $19,720 | $13,952 | $40,650 | $26,440 |
| Gross Margin % | 28.1% | 29.2% | 28.8% | 27.5% |
| Operating Profit | $4,107 | $4,434 | $8,917 | $7,009 |
| Net Earnings (Attributable to Kewaunee) | $2,445 | $3,008 | $5,538 | $5,201 |
| Diluted EPS | $0.82 | $1.01 | $1.86 | $1.75 |
| Operating Cash Flow (6 Months) | $1,526 | |||
| Capital Expenditures (6 Months) | ($2,341) | |||
| Cash & Equivalents (Oct 31, 2025) | $12,594 | |||
| Total Debt (Oct 31, 2025) | ~$35.3M (Excl. Leases) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 46.7% year-over-year for the quarter and 46.8% for the six-month period. This growth is primarily attributable to the Nu Aire acquisition, which contributed $19.4 million in revenue for the quarter and $39.1 million for the six months.
- Segment Performance: Domestic sales rose 51.7% (quarter) and 52.3% (six months), while International sales increased 31.0% (quarter) and 30.5% (six months), driven by large project deliveries booked in prior periods.
- Profitability: While revenue surged, Net Earnings attributable to Kewaunee decreased 18.7% for the quarter ($2.4M vs $3.0M) due to higher operating expenses and interest costs. However, for the six-month period, Net Earnings increased 6.5% ($5.5M vs $5.2M).
- Operating Expenses: Increased significantly (63.9% for the quarter) due to the inclusion of Nu Aire operations, higher SG&A wages, benefits, and stock-based compensation.
- Interest Expense: Doubled for the quarter ($1.1M vs $0.4M) and more than doubled for the six months ($2.1M vs $0.9M) due to higher borrowing levels and interest rates associated with the acquisition financing.
Guidance, Outlook, and Risks
- Backlog: Order backlog stands at $192.9 million as of October 31, 2025, near record levels, indicating strong future revenue visibility despite volatility in project delivery timelines.
- Outlook: Management notes that quoting and booking activity remain strong. The Company is focused on organic and inorganic growth and strategic investments in people and technology.
- Subsequent Events: On December 4, 2025, the Company amended its Loan Agreement with PNC to facilitate the full repayment of the $23.0 million subordinated Seller Notes issued during the Nu Aire acquisition. The repayment was completed on that date.
- Tax Legislation: The Company is evaluating the impact of the "One Big Beautiful Bill Act" (OBBBA) enacted on July 4, 2025, which includes tax reform provisions affecting businesses. The full impact is not yet reflected in the financial statements.
- Risks: Key risks include dependence on laboratory construction projects, fluctuations in raw material costs (steel, wood, epoxy resin), foreign currency fluctuations, and the ability to realize anticipated synergies from the Nu Aire acquisition.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of cost synergies and revenue cross-selling opportunities from the Nu Aire acquisition, which drove the majority of revenue growth but also increased operating leverage.
- Debt Servicing: Confirm the impact of the December 2025 Seller Note repayment on future interest expense and liquidity, noting the Company utilized a new term loan and revolver to fund this.
- Margin Pressure: Monitor gross margin trends, which dipped slightly in the quarter (28.1% vs 29.2% prior year) due to lower manufacturing volumes and productivity in the laboratory construction segment.
- Cash Flow Conversion: Review the divergence between Net Earnings and Operating Cash Flow ($1.5M for six months), which was impacted by decreases in accounts payable and deferred revenue.
- Backlog Conversion: Assess the timeline for converting the $192.9 million backlog into recognized revenue, given the Company's stated volatility in project delivery schedules.